Financial Enhancement Group’s CVS Health CVS Stock Holding History

Financial Enhancement Group’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2	Closed	–	–	164
2022 Q3	$0	Hold	2	–	–	﹤0.01%	305
2022 Q2	$0	Hold	2	–	–	﹤0.01%	306
2022 Q1	$0	Hold	2	–	–	﹤0.01%	311
2021 Q4	$0	Hold	2	–	–	﹤0.01%	275
2021 Q3	$0	Hold	2	–	–	﹤0.01%	281
2021 Q2	$0	Hold	2	–	–	﹤0.01%	277
2021 Q1	$0	Buy	+2	New	+$146	﹤0.01%	283
2020 Q2	–	Sell	-180	Closed	-$11K	–	256
2020 Q1	$11K	Hold	180	–	–	﹤0.01%	191
2019 Q4	$13K	Hold	180	–	–	﹤0.01%	181
2019 Q3	$11K	Hold	180	–	–	﹤0.01%	194
2019 Q2	$10K	Hold	180	–	–	﹤0.01%	192
2019 Q1	$10K	Hold	180	–	–	﹤0.01%	212
2018 Q4	$14K	Hold	180	–	–	﹤0.01%	174
2018 Q3	$14K	Hold	180	–	–	﹤0.01%	174
2018 Q2	$12K	Sell	180 -93	-34%	-$6.13K	﹤0.01%	171
2018 Q1	$17K	Buy	+273	New	+$19.6K	0.01%	163

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Financial Enhancement Group's CVS Position: Q4 2022 in Review

Financial Enhancement Group sold out of CVS Health (CVS) in Q4 2022, closing a stake of 2 shares.

Financial Enhancement Group first reported a position in CVS in Q1 2018 and held it in 16 quarters. The position peaked at $17K in Q1 2018. 2,405 funds tracked by Wall St. Rank hold CVS as of Q4 2022.

Financial Enhancement Group reported no remaining CVS Health position as of Q4 2022 after selling out during the quarter.
Financial Enhancement Group sold 2 CVS Health shares in Q4 2022.
Financial Enhancement Group first reported a position in CVS Health in Q1 2018 and held it in 16 quarters.
Financial Enhancement Group's CVS Health position peaked at $17K in Q1 2018.
2,405 funds tracked by Wall St. Rank held CVS Health as of Q4 2022.

Based on Financial Enhancement Group's 13F filing for Q4 2022, filed 9 Feb 2023.